Rigel Pharmaceuticals RIGL Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $294.28M+64.1% | $179.28M+53.4% | $116.88M-2.8% | $120.24M-19.4% | ||
| $19.62M+5.2% | $18.65M+162% | $7.11M+307% | $1.75M+61.5% | ||
| $274.66M+71.0% | $160.63M+46.3% | $109.77M-7.4% | $118.49M-20.0% | ||
| 93.3%+3.7pp | 89.6%-4.3pp | 93.9%-4.6pp | 98.5%-0.7pp | ||
| $33.3M+42.4% | $23.38M-4.7% | $24.52M-59.3% | $60.27M-7.6% | ||
| $115.9M+2.5% | $113.06M+6.9% | $105.74M-6.0% | $112.45M+22.4% | ||
| $168.82M+8.9% | $155.09M+12.9% | $137.37M-21.9% | $175.79M+8.7% | ||
| $125.47M+419% | $24.19M+208% | -$22.46M+61.0% | -$57.63M-361% | ||
| 42.6%+29.1pp | 13.5%+32.7pp | -19.2%+28.7pp | -47.9%-39.6pp | ||
| $7.32M-7.6% | $7.92M+15.2% | $6.87M+85.4% | $3.71M-23.7% | ||
| $121.83M+563% | $18.37M+173% | -$25.09M+58.2% | -$59.97M-246% | ||
| -$245.2M-27,932% | $881K— | $0— | —— | ||
| $367.02M+1,999% | $17.49M+168% | -$25.83M+56.9% | -$59.97M-235% | ||
| 124.7%+115pp | 9.8%+31.9pp | -22.1%+27.8pp | -49.9%-37.9pp | ||
| $19.47+1,887% | $0.98+168% | -$1.44+58.1% | -$3.44-2,767% | ||
| $127.88M+384% | $26.42M+225% | -$21.22M+62.5% | -$56.63M-400% | ||
| 43.5%+28.7pp | 14.7%+32.9pp | -18.2%+28.9pp | -47.1%-39.5pp | ||
| $125.47M+419% | $24.19M+208% | -$22.46M+61.0% | -$57.63M-361% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Rigel Pharmaceuticals's revenue?
- Rigel Pharmaceuticals (RIGL) generated $299.8M in revenue over the trailing twelve months, up 47.6% year over year.
- Is Rigel Pharmaceuticals profitable?
- Rigel Pharmaceuticals reported $364.2M in net income over the trailing twelve months, a 121.5% net margin.
- What are Rigel Pharmaceuticals's profit margins?
- Gross margin is 93.4% and operating margin is 41.6%, with a 121.5% net margin.
- What is Rigel Pharmaceuticals's earnings per share?
- Rigel Pharmaceuticals's diluted EPS over the trailing twelve months is $19.28.
- Where does Rigel Pharmaceuticals's income statement data come from?
- Every line is extracted from Rigel Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
